Results 241 to 250 of about 441,130 (284)

Dual Physiological Barriers Bypassed by a Silk‐Based Supramolecular Protein Delivery Platform for Neuroinflammation Mitigation in Alzheimer's Disease

Advanced Science, EarlyView.
A supramolecular nanocomplex based on phenolic‐modified silk sericin is developed to deliver antioxidant enzymes across the blood–brain barrier and escape lysosomal degradation. This dual‐barrier‐crossing system reduces neuroinflammation and improves cognitive performance in Alzheimer's disease mouse model, offering a promising strategy for protein ...
Doudou Hu, Tiandong Li, Jian He, Yujian Jiang, Yeyuan Wang, Jingchen Sun   +5 more
wiley   +1 more source

Randomised controlled trial on the efficacy of adding cognitive remediation therapy to methylphenidate in adult patients with attention deficit hyperactivity disorder and addictive disorders (META): CRT in ADHD and addiction - META study protocol. [PDF]

BMJ Open
Cabelguen C, Challet-Bouju G, Thiabaud E, Donnio Y, Lefebvre L, Hardouin JB, Grall-Bronnec M.   +6 more
europepmc   +1 more source

Time Trends in the Comorbid Psychiatric Disorders Among Children and Adolescents With Intellectual Disability in Korea: A Nationwide Study From 2012-2021. [PDF]

J Korean Med Sci
Joo MA, Kang NR, Kim JY, Lee HJ.
europepmc   +1 more source

Auditory integration training techniques for brain stimulation to reduce attention deficit hyperactivity disorder symptoms and improve academic and behavioral skills among children with learning disabilities. [PDF]

J Med Life
Alyoubi R, Issa A, Al-Mwaulid H, Alyazidi A.   +3 more
europepmc   +1 more source

Measuring Accuracy (Classification Probabilities, Positive, and Negative Predictive Values) of Executive Function Electroencephalogram Metrics in Attention-Deficit/Hyperactivity Disorder Diagnosis: Protocol for and Perspectives From the SINCRONIA Study.

JMIR Res Protoc
Blasco-Fontecilla H, Sánchez-Cerezo J, Gómez I, Abreu-Fernández G, Ortiz S, Villoria JF, Blanco M, García A, Ballesteros J, Martínez R, Gálvez G, Maestú F, López-Medrano Á.   +12 more
europepmc   +1 more source

Prenatal exposure to buprenorphine or methadone and adverse neurodevelopmental outcomes: population based cohort study.

BMJ
Friedrich S, Huybrechts KF, Straub L, Hernandez-Diaz S, Zhu Y, Hahn G, Mogun H, Jones HE, Connery HS, Davis JM, Gray KJ, Lester B, Terplan M, Bateman BT.   +13 more
europepmc   +1 more source

DSM-5 Changes, COVID-19, and ADHD Diagnosis Rates in Individuals Younger Than 30 Years.

JAMA Netw Open
Cui Z, Ambasta A, Thompson W, Bassett K, Carney G, Dormuth C.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Attention-deficit hyperactivity disorder

The Lancet, 2005
Attention-deficit hyperactivity disorder (ADHD) is a disorder of inattention, impulsivity, and hyperactivity that affects 8-12% of children worldwide. Although the rate of ADHD falls with age, at least half of children with the disorder will have impairing symptoms in adulthood.
Joseph Biederman, Stephen V Faraone
openaire   +4 more sources